https://doi.org/10.4081/reumatismo.2015.839
Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren’s syndrome: findings in serum and minor salivary glands
Submitted: 20 July 2015
Accepted: 10 November 2015
Published: 9 February 2016
Accepted: 10 November 2015
Abstract Views: 1952
PDF: 1072
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Alunno, A., Caneparo, V., Carubbi, F., Bistoni, O., Caterbi, S., Gariglio, M., … Gerli, R. (2016). Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren’s syndrome: findings in serum and minor salivary glands. Reumatismo, 67(3), 85–90. https://doi.org/10.4081/reumatismo.2015.839
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- N. Bassi, R. Luisetto, A. Ghirardello, M. Gatto, B. Bottazzi, Y. Shoenfeld, L. Punzi, A. Doria, Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant , Reumatismo: Vol. 64 No. 6 (2012)
- M.C. Leone, A. Alunno, G. Cafaro, V. Valentini, E. Marcucci, E. Bartoloni, R. Gerli, The clinical spectrum of primary Sjögren’s syndrome: beyond exocrine glands , Reumatismo: Vol. 69 No. 3 (2017)
- B. Palterer, G. Vitiello, D. Cammelli, First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome , Reumatismo: Vol. 69 No. 2 (2017)
- O. Zengin, M. E. Onder, M. A. Sarica, I. H. Turkbeyler, G. Kimyon, Z. H. Demir, H. Yildiz, B. Kisacik, A. M. Onat, Systemic vasculitis in a patient with rhupus syndrome , Reumatismo: Vol. 67 No. 4 (2015)
- M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani, The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus , Reumatismo: Vol. 68 No. 3 (2016)
- S. Muller, S. Hider, T. Helliwell, R. Partington, C. Mallen, The real evidence for polymyalgia rheumatic as a paraneoplastic syndrome , Reumatismo: Vol. 70 No. 2 (2018)
- S. Scriffignano, F.M. Perrotta, M. Ricci, B. Carabellese, E. Lubrano , Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review , Reumatismo: Early Access
- A. Alunno, O. Bistoni, E. Bartoloni Bocci, S. Caterbi, B. Bigerna, A. Pucciarini, A. Tabarrini, R. Mannucci, D. Beghelli, B. Falini, R. Gerli, IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren’s syndrome , Reumatismo: Vol. 65 No. 4 (2013)
- M. Benucci, F. Li Gobbi, A. Del Rosso, G. Gambacorta, A. Mannoni, Association between Serum Amiloid A (SAA) in salivary glands and high levels of circulating β2-microglobulin in patients with Sjögren syndrome , Reumatismo: Vol. 55 No. 2 (2003)
- L. Iaccarino, A. Ghirardello, M. Zen, D. Villalta, A. Tincani, L. Punzi, A. Doria, Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus , Reumatismo: Vol. 64 No. 5 (2012)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
